Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-06

Clinical Trial Update: Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial evaluating delivery timing for morbidly adherent placenta (placenta accreta) has been withdrawn from the study. The sponsor is The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Morbidly Adherent Placenta, Placenta Accreta | NA | Status: WITHDRAWN